Two Sigma Securities’s Biomerica BMRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,472
Closed -$29.6K 1502
2025
Q3
$29.6K Buy
+10,472
New +$33.1K ﹤0.01% 1065
2025
Q2
Sell
-2,943
Closed -$13.3K 1532
2025
Q1
$13.3K Sell
2,943
-3,956
-57% -$19.6K ﹤0.01% 1176
2024
Q4
$16.6K Buy
6,899
+4,781
+226% +$12.6K ﹤0.01% 1350
2024
Q3
$5.55K Sell
2,118
-248
-10% -$710 ﹤0.01% 2663
2024
Q2
$8.32K Buy
2,366
+695
+42% +$3.54K ﹤0.01% 2828
2024
Q1
$11.1K Sell
1,671
-155
-8% -$1.26K ﹤0.01% 2752
2023
Q4
$18.3K Buy
+1,826
New +$13.8K ﹤0.01% 2735

Other funds holding BMRA

Two Sigma Securities's BMRA Position: Q4 2025 in Review

Two Sigma Securities sold out of Biomerica (BMRA) in Q4 2025, closing a stake of 10,472 shares — an estimated $29.6K sold.

Two Sigma Securities first reported a position in BMRA in Q4 2023 and held it in 7 quarters. The position peaked at $29.6K in Q3 2025. 13 funds tracked by Wall St. Rank hold BMRA as of Q4 2025.

  • Two Sigma Securities reported no remaining Biomerica position as of Q4 2025 after selling out during the quarter.
  • Two Sigma Securities sold 10,472 Biomerica shares in Q4 2025, an estimated $29.6K.
  • Two Sigma Securities first reported a position in Biomerica in Q4 2023 and held it in 7 quarters.
  • Two Sigma Securities's Biomerica position peaked at $29.6K in Q3 2025.
  • 13 funds tracked by Wall St. Rank held Biomerica as of Q4 2025.

Based on Two Sigma Securities's 13F filing for Q4 2025, filed 17 Feb 2026.